Skip to main content
. 2017 Nov 15;67(1):260–272. doi: 10.1002/hep.29179

Figure 3.

Figure 3

Summarized ROC curves and diagnostic performance by AUROC estimated using a random effect approach for all patients and for HCV, HBV, and NAFLD patients.